Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study to Assess 600 mg Boric Acid Vaginal Inserts With 7- or 14-Days Treatment of Vulvovaginal Candidiasis (VVC)

NCT07109869 is registered in ClinicalTrials.gov with pH-D Feminine Health LLC as lead sponsor.

NCT NCT07109869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07109869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study to Assess 600 mg Boric Acid Vaginal Inserts With 7- or 14-Days Treatment of Vulvovaginal Candidiasis (VVC)
Lead sponsor
pH-D Feminine Health LLC
Phase
Phase 3
Overall status
Completed
Start date
August 8, 2025
Completion date
August 12, 2026
Enrollment
333 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal candidiases, vulvovaginal candidiasis (vvc), vulvovaginal candidiasis, genital